These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1501 related articles for article (PubMed ID: 31996915)
1. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Liu T; Wei Q; Jin J; Luo Q; Liu Y; Yang Y; Cheng C; Li L; Pi J; Si Y; Xiao H; Li L; Rao S; Wang F; Yu J; Yu J; Zou D; Yi P Nucleic Acids Res; 2020 Apr; 48(7):3816-3831. PubMed ID: 31996915 [TBL] [Abstract][Full Text] [Related]
2. YTHDF1 facilitates esophageal cancer progression via augmenting m6A-dependent TINAGL1 translation. Zhang L; Cai E; Xu Y; Liu Z; Zheng M; Sun Z; Pei D; Wang Q Cell Signal; 2024 Oct; 122():111332. PubMed ID: 39098703 [TBL] [Abstract][Full Text] [Related]
3. HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation. Li Q; Ni Y; Zhang L; Jiang R; Xu J; Yang H; Hu Y; Qiu J; Pu L; Tang J; Wang X Signal Transduct Target Ther; 2021 Feb; 6(1):76. PubMed ID: 33619246 [TBL] [Abstract][Full Text] [Related]
4. YTHDF1 promotes gallbladder cancer progression via post-transcriptional regulation of the m6A/UHRF1 axis. Chen J; Bai X; Zhang W; Yan Z; Liu Y; Zhou S; Wu X; He X; Yang A J Cell Mol Med; 2024 May; 28(9):e18328. PubMed ID: 38683130 [TBL] [Abstract][Full Text] [Related]
5. YTHDF1 Promotes Cyclin B1 Translation through m Lou X; Ning J; Liu W; Li K; Qian B; Xu D; Wu Y; Zhang D; Cui W Cells; 2021 Jul; 10(7):. PubMed ID: 34359836 [TBL] [Abstract][Full Text] [Related]
6. RUVBL1/2 Blockade Targets YTHDF1 Activity to Suppress m6A-Dependent Oncogenic Translation and Colorectal Tumorigenesis. Chen D; Ji F; Zhou Q; Cheung H; Pan Y; Lau HC; Liang C; Yang Z; Huang P; Wei Q; Cheung AH; Kang W; Chen H; Yu J; Wong CC Cancer Res; 2024 Sep; 84(17):2856-2872. PubMed ID: 38900944 [TBL] [Abstract][Full Text] [Related]
7. ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner. Li P; Shi Y; Gao D; Xu H; Zou Y; Wang Z; Li W Int J Biol Sci; 2022; 18(16):6145-6162. PubMed ID: 36439881 [No Abstract] [Full Text] [Related]
8. m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells. Hao L; Wang JM; Liu BQ; Yan J; Li C; Jiang JY; Zhao FY; Qiao HY; Wang HQ Biochim Biophys Acta Mol Cell Res; 2021 Jan; 1868(1):118878. PubMed ID: 33011193 [TBL] [Abstract][Full Text] [Related]
9. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7). Wei K; Gao Y; Wang B; Qu YX Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522 [TBL] [Abstract][Full Text] [Related]
10. YTHDF1-enhanced iron metabolism depends on TFRC m Ye J; Wang Z; Chen X; Jiang X; Dong Z; Hu S; Li W; Liu Y; Liao B; Han W; Shen J; Xiao M Theranostics; 2020; 10(26):12072-12089. PubMed ID: 33204330 [No Abstract] [Full Text] [Related]
11. METTL3/YTHDF1 m Zhi D; Zhou K; Liu S; Yu W; Dong M; Yan C Pathol Res Pract; 2024 Jan; 253():155047. PubMed ID: 38154356 [TBL] [Abstract][Full Text] [Related]
12. RNA m6A reader YTHDF1 facilitates inflammation via enhancing NLRP3 translation. Hao WY; Lou Y; Hu GY; Qian CY; Liang WR; Zhao J; Wang XH Biochem Biophys Res Commun; 2022 Aug; 616():76-81. PubMed ID: 35649302 [TBL] [Abstract][Full Text] [Related]
13. YTHDF1 promotes intrahepatic cholangiocarcinoma progression via regulating EGFR mRNA translation. Huang X; Zhu L; Wang L; Huang W; Tan L; Liu H; Huo J; Su T; Zhang M; Kuang M; Li X; Dai Z; Xu L J Gastroenterol Hepatol; 2022 Jun; 37(6):1156-1168. PubMed ID: 35233828 [TBL] [Abstract][Full Text] [Related]
14. The RNA m6A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression. Hong YG; Yang Z; Chen Y; Liu T; Zheng Y; Zhou C; Wu GC; Chen Y; Xia J; Wen R; Liu W; Zhao Y; Chen J; Gao X; Chen Z Cancer Res; 2023 Mar; 83(6):845-860. PubMed ID: 36634204 [TBL] [Abstract][Full Text] [Related]
15. KIAA1429 increases FOXM1 expression through YTHDF1-mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma. Wu Y; Luo Y; Yao X; Shi X; Xu Z; Re J; Shi M; Li M; Liu J; He Y; Du X Cell Biol Toxicol; 2024 Jul; 40(1):58. PubMed ID: 39060874 [TBL] [Abstract][Full Text] [Related]
16. YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner. Chen H; Yu Y; Yang M; Huang H; Ma S; Hu J; Xi Z; Guo H; Yao G; Yang L; Huang X; Zhang F; Tan G; Wu H; Zheng W; Li L Cell Biosci; 2022 Feb; 12(1):19. PubMed ID: 35197112 [TBL] [Abstract][Full Text] [Related]
17. YTHDF1 Promotes Gastric Carcinogenesis by Controlling Translation of Pi J; Wang W; Ji M; Wang X; Wei X; Jin J; Liu T; Qiang J; Qi Z; Li F; Liu Y; Ma Y; Si Y; Huo Y; Gao Y; Chen Y; Dong L; Su R; Chen J; Rao S; Yi P; Yu S; Wang F; Yu J Cancer Res; 2021 May; 81(10):2651-2665. PubMed ID: 32788173 [TBL] [Abstract][Full Text] [Related]
18. Eukaryotic initiation factor 3, subunit C silencing inhibits cell proliferation and promotes apoptosis in human ovarian cancer cells. Wen F; Wu ZY; Nie L; Zhang QZ; Qin YK; Zhou ZL; Wu JJ; Zhao X; Tan J; Sawmiller D; Zi D Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31316002 [TBL] [Abstract][Full Text] [Related]
19. N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer. Wang S; Gao S; Zeng Y; Zhu L; Mo Y; Wong CC; Bao Y; Su P; Zhai J; Wang L; Soares F; Xu X; Chen H; Hezaveh K; Ci X; He A; McGaha T; O'Brien C; Rottapel R; Kang W; Wu J; Zheng G; Cai Z; Yu J; He HH Gastroenterology; 2022 Apr; 162(4):1183-1196. PubMed ID: 34968454 [TBL] [Abstract][Full Text] [Related]
20. N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression. Zhang X; Su T; Wu Y; Cai Y; Wang L; Liang C; Zhou L; Wang S; Li XX; Peng S; Kuang M; Yu J; Xu L Cancer Res; 2024 Mar; 84(6):827-840. PubMed ID: 38241695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]